医学档案

  • 国际标准期刊号: 1989-5216
  • 期刊 h 指数: 22
  • 期刊引用分数: 4.96
  • 期刊影响因子: 4.44
索引于
  • Genamics 期刊搜索
  • 中国知网(CNKI)
  • 研究期刊索引目录 (DRJI)
  • OCLC-WorldCat
  • 普罗奎斯特传票
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • 谷歌学术
  • 秘密搜索引擎实验室
分享此页面

抽象的

Evidence-based approach to fever and fever of unknown origin in Fiji

Abhijit Gogoi*, Judith Apondi Oremo, Ivor Xavier Tsika, ElisonJimmy, Alphones Kuma, Muhammed Ilyas Harun, Mercy Gogo

While Fiji a South Pacific Country is an archipelago of more than 300 islands. With an approximate population of 889, 953, Fiji faces a growing burden of several communicable diseases and non-communicable disease including fever of unknown origin. Surveillance data suggest that Fever has become increasingly common in rural areas of Fiji and is more frequent amongst acute respiratory infections, dengue and viral infections. Appropriate measures are taken by the Ministry of Health Fiji to reduce the potential for relapse and reinfection in clinical cases, by encouraging proper hand hygiene of food and drink handlers, water and sanitation agencies to review current sanitation practices and vaccination policy targeting epidemiologically relevant populations. This article initial aim is to examine fever of unknown origin around the Pacific and Fiji but due to limited data available we mainly focus on cases of diseases that have at least fever as one of the associated symptoms in 2018 within the four divisions of Fiji namely the Northern Central, Eastern and Western regions. A retrospective study with data obtained from the Fiji Ministry of Health 2018 and National Notifiable Disease Surveillance System Weekly Bulletin. Acute respiratory infection is the leading cause of FUO and fever in Fiji with an average of 64% cases in 2018 followed by Dengue at 14%. Patient in significant numbers continue to present fever/FUO due to a wide range of diseases. Future prospective data collection is recommended to identify the cause and trends, which inform the Ministry of Health and future research priorities hence allowing the development of appropriate policies and clinical guidelines for management of fever/FUO.